BioTech Medics has received preliminary independent clinical testing of its patented shban hand sanitizer solution to demonstrate that it kills the H1N1 (Swine) Influenza A virus.
Preliminary lab results indicated that Shban hand sanitizer solution at three different concentrates caused a reduction (killing) of the H1N1 virus titer within one minute.
The company said that the Shban Solution has continued to work and increased the kill rate of the H1N1 virus titer, over a testing period of 30 minutes. The study confirmed the long-lasting effectiveness of Shban Solution in reducing germs, bacteria and viruses.
Reportedly, Shban has also been independently clinically tested to prove that it is non-toxic (causing no dermatitis on human skin).
Moreover, Shban is protected under US Letters of Patent No. 5,514,808, 5,574,050, 5,679,711 and 5,585,391 and pending international patents.
Shban, in previous in-vitro and in vivo testing, has been evaluated for its antimicrobial properties against H5N1 Avian Bird Influenza, Staph. Aureus, Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa.
The company is releasing Shban hand sanitizer solution this fall, in 1.5oz and 16oz bottles together with Shban Hand Wipe Towelettes.